| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/24/2003 | CA2470520A1 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| 07/24/2003 | CA2470503A1 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 07/24/2003 | CA2470498A1 Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| 07/24/2003 | CA2470430A1 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | CA2470413A1 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 07/24/2003 | CA2470400A1 Cultured and encapsulated pancreatic stem cells |
| 07/24/2003 | CA2469156A1 Center-filled chewing gum containing calcium |
| 07/24/2003 | CA2467764A1 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions. |
| 07/24/2003 | CA2464472A1 Antibody targeting compounds |
| 07/24/2003 | CA2464131A1 Compositions and methods for controlled release |
| 07/23/2003 | EP1329458A2 Peptides that lower blood glucose levels |
| 07/23/2003 | EP1329226A2 Hapten-Carrier Conjugates for use in Drug Abuse Therapy |
| 07/23/2003 | EP1329225A2 Transdermal device containing polyvinylpyrrolidone as solubility enhancer |
| 07/23/2003 | EP1329224A1 Solution formulations having long-term stability |
| 07/23/2003 | EP1329221A1 Polymeric micelle containing cisplatin enclosed therein and use thereof |
| 07/23/2003 | EP1328624A2 B7-like molecules and uses thereof |
| 07/23/2003 | EP1328622A2 Protein c or activated protein c-like molecules |
| 07/23/2003 | EP1328546A2 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 07/23/2003 | EP1328521A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 07/23/2003 | EP1328320A2 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 07/23/2003 | EP1328300A1 Self-adhesive hydratable matrix for topical therapeutic use |
| 07/23/2003 | EP1328297A2 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 07/23/2003 | EP1328296A2 Camptothecin conjugates |
| 07/23/2003 | EP1328288A2 Protein mixtures for wound healing |
| 07/23/2003 | EP1328280A1 New composition and method for the treatment of dysglucaemia |
| 07/23/2003 | EP1328266A1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 07/23/2003 | EP1328265A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 07/23/2003 | EP1328260A2 Methods and products related to pulmonary delivery of polysaccharides |
| 07/23/2003 | EP1328259A2 Transdermal therapeutic systems comprising photosensitive active substances |
| 07/23/2003 | EP1328258A1 A controlled-release, parenterally administrable microparticle preparation |
| 07/23/2003 | EP1328255A1 Composition and method for stable injectable liquids |
| 07/23/2003 | EP1328254A2 Lipid formulations for target delivery |
| 07/23/2003 | EP1328253A2 Administration of a thiol-based chemoprotectant compound |
| 07/23/2003 | EP1328252A2 Transdermal pharmaceutical delivery composition |
| 07/23/2003 | EP1328251A2 Methylphenidate modified release formulations |
| 07/23/2003 | EP1328250A2 Method for determining the release of a peptide from a sustained release polylactide formulation |
| 07/23/2003 | EP1328245A1 Dental care compositions |
| 07/23/2003 | EP1328214A1 Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications |
| 07/23/2003 | EP1251826B1 Diclofenamide suspension gel |
| 07/23/2003 | EP1189608B1 Levodopa/carbidopa/entacapone pharmaceutical preparation |
| 07/23/2003 | EP1173154A4 Chewing gum with dental benefits including calcium in a food grade acid |
| 07/23/2003 | EP1140199B1 Hyaluronate lyase used for promoting penetration in topical agents |
| 07/23/2003 | EP1140006B1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis |
| 07/23/2003 | EP1107741B1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 07/23/2003 | EP1077727B1 Adhesive microsphere drug delivery composition |
| 07/23/2003 | EP1069913B1 Gelling ophthalmic compositions containing xanthan gum |
| 07/23/2003 | EP1053012B1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections |
| 07/23/2003 | EP1007024B1 Delayed-release dosage forms of sertraline |
| 07/23/2003 | EP0957940B1 Pharmaceutical compositions containing gellants in the form of alkyl amides of di- and tri-carboxylic acids |
| 07/23/2003 | EP0951294B1 Method of producing concentrated non-buffered solutions of fibronectin |
| 07/23/2003 | EP0942724B1 Gel formulations for topical drug delivery |
| 07/23/2003 | EP0914166B1 Methods of terminal sterilization of biological products |
| 07/23/2003 | EP0874640B1 Cyclosporin formulation |
| 07/23/2003 | EP0871476B1 Dried blood factor composition comprising trehalose |
| 07/23/2003 | EP0855919B1 Induction of mucosal immune responses by vitamin d3 and antigen-encoding dna complexe to cationic lipid |
| 07/23/2003 | EP0743958B1 Avidin-biotin immunoconjugates |
| 07/23/2003 | EP0625910B1 Dual carrier immunogenic construct |
| 07/23/2003 | CN1432068A Methods for ansamitocin prodn. method |
| 07/23/2003 | CN1432067A Sperm-DNA complexes for genetically modifying non-human animals |
| 07/23/2003 | CN1432023A Reductive alkylation process on glycopeptides |
| 07/23/2003 | CN1431971A Micropowdered barium sulfate |
| 07/23/2003 | CN1431964A Methods of producing terminally sterilized topical patch preparation |
| 07/23/2003 | CN1431919A Device and liquid formulations |
| 07/23/2003 | CN1431916A Oral delivery method and compsn. for solid medications or dietary supplements |
| 07/23/2003 | CN1431908A Kits and methods for optimizing efficacy of chondroprotective compsns. |
| 07/23/2003 | CN1431906A Percutaneous absorption type steroid prepn. for external use |
| 07/23/2003 | CN1431903A Minoxidil-containing preparations |
| 07/23/2003 | CN1431900A Methods and compsns. useful in enhancing oxygon delivery to cells |
| 07/23/2003 | CN1431895A Compsns-and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| 07/23/2003 | CN1431874A Use of polyphosphate as tooth erosion inhibitor in acidic compsns. |
| 07/23/2003 | CN1431041A Granular body contg. polydroxy alkoxide acid ester |
| 07/23/2003 | CN1431021A Biologic spongy body used for treating gynaecology disease and produing method thereof |
| 07/23/2003 | CN1430959A Compsn. contg. 5-[4-[2-(N-methyl-N-2-pyridyl) amino-) oxethyl] beazyl] thiazolidine-2,4-tetraethyldiaminobenzophenone |
| 07/23/2003 | CN1430958A Liniment of levamisole hydrochloride |
| 07/23/2003 | CN1115148C Skin penetration enhancing components |
| 07/22/2003 | US6596874 Salt formation by reaction using benzenesulfonic acid |
| 07/22/2003 | US6596861 Subjecting reaction mixture comprising a bacterial polysaccharide, an amino compound and a reducing agent to microwave radiation; useful in conjugating polysaccharides to polypeptides and vaccine development |
| 07/22/2003 | US6596844 Flowable, have an increased bulk density, and a low amount of dust |
| 07/22/2003 | US6596791 Polymer complexes of glucuronoglucanes |
| 07/22/2003 | US6596779 Stable emulsion, process for the preparation thereof and agent for this purpose |
| 07/22/2003 | US6596777 Moisture containing compositions that are spreadable onto and adherable to biomembranes |
| 07/22/2003 | US6596757 Taxanes linked to a cell binding agent. A therapeutic composition for killing selected cell populations comprising: (A) a cytotoxic amount of one or more polyethylene glycol-containing taxanes covalently bonded to a cell binding |
| 07/22/2003 | US6596706 For the treatment of circulatory diseases cerebral diseases |
| 07/22/2003 | US6596704 Spraying, painting or squirting gellan gum composition on the wound or skin injury to form an immobile gel |
| 07/22/2003 | US6596697 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 07/22/2003 | US6596491 Tenascin-C nucleic acid ligands |
| 07/22/2003 | US6596317 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
| 07/22/2003 | US6596311 Multiparticulate drug, disintegrants, water insoluble and soluble inorganic excipients; nonbrittle; controlled, sus-tained or targeted release; gastric protection; taste masking |
| 07/22/2003 | US6596309 Together with lipophilic silicone oil carriers in the form of a soft gelatin capsule |
| 07/22/2003 | US6596298 Pullulan and antimicrobially effective amounts of thymol, methyl salicylate, eucalyptol and menthol |
| 07/22/2003 | US6596296 Three dimensional matrices for growing cells; controlled delivery of therapeutic agents |
| 07/22/2003 | US6596295 Aqueous solution for treating degenerative or autoimmune diseases and/or as an immunomodulatory agent |
| 07/22/2003 | US6596293 Preparing polymer delivery vehicle for controlled release of bioactive agent |
| 07/22/2003 | US6596287 Products for topical applications comprising oil bodies |
| 07/22/2003 | US6596286 Topical moisture regulating compositions |
| 07/22/2003 | US6596284 Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers |
| 07/22/2003 | US6596262 Modulated release particles for aerosol delivery |
| 07/22/2003 | US6596257 In situ labeling of preferential tissues; obtain tissue, incubate with conjugate, monitor sample for visible signal |
| 07/22/2003 | CA2353693C Pharmaceutical composition containing citalopram |
| 07/22/2003 | CA2269923C Pharmaceutical compositions containing plasma protein |